Joel Allen

Dr Joel Allen is a Principal Research Fellow at the University of Southampton, specializing in viral glycobiology and immunogen design. His research focuses on characterizing glycosylation patterns in viral envelope proteins to improve HIV vaccine designs. He collaborates extensively with the Crispin laboratory and contributes to projects like the Institute for Protein Design's structure-based immunogen initiatives. His work combines mass spectrometry techniques with virological studies to understand antibody-antigen interactions critical for vaccine efficacy.

Key research areas include HIV-1 envelope glycoprotein diversity, SARS-CoV-2 glycan analysis, and development of multivalent vaccine platforms. Allen has co-authored influential studies in Nature Immunology, Science, and NPJ Vaccines, addressing topics from UVC inactivation mechanisms to antibody precursor priming in nonhuman primates. He is actively involved in interdisciplinary teams exploring glycan-driven immune responses and next-generation vaccine technologies.